Seminarios virtuales

There has never been a more exciting and promising time in pharmacological research in obesity. It is now broadly accepted that obesity is not just the lack of willpower but a complex chronic disease, with increased morbidity and mortality, that can be managed with the right treatment.

Neurodegenerative Disorders are one of the most burdensome conditions on the planet not only for the patients, but also caregivers, health care providers, and the health care systems. Over the decades there has been a major focus to drive the science and research in the field, leading to better and more precise treatment options for the patients.

Join us for an insightful webinar delving into the expanding horizons of CAR-T therapy beyond oncology. CAR-T therapy stand at the forefront of medical innovation, offering not only novel treatments for cancer but also promising avenues for addressing a wide array of non-oncological diseases.

As the frontiers of the multi-disciplined scientific arena, cell and gene therapy is unlocking their potential in treating those incurable illnesses, thus changing the lives of patients. While fueled with the momentum of investment opportunities, challenges in clinical operations and market access are posed in front of Asia-Pacific region-located biotech companies.

In this dynamic panel-type webinar, the expert speakers will explore how to speed drug development and improve return on investment (ROI) by adopting a “3-D” approach to trials focusing on design, diversity and digitalization.

As drug development progresses, regulators require a clear picture of how products are metabolized in the human body, and the risks associated with compounds that may linger in critical organs.

Reducing Patient Burden, Improving Efficiency and Incorporating Cell and Gene Therapy